← All stocks

CME Group

CME Net selling
CIK 0001156375 #116 in the set updated 22 Sep 2026
Bought (120 mo)
$11.55M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$241.77M
$1.41M on a plan · $45.70M straight out of an exercise
Sold at will
$194.66M
253 of 330 sales
Net
−$230.23M
−$183.12M against sales at will

By person

51 insiders · 380 transactions
8.7×

Terrence A. Duffy holds 8.7 times base salary in stock. $17.49M of shares against $2.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Terrence A. Duffy last reported holding, valued at $280.11, the price Common Stock Class A was last bought or sold at on the open market here, on 14 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
DUFFY TERRENCE A
Chairman and CEO
$441.14K (7)
$80.83M (20)
−$80.39M
62,442
0.017%
$17.49M
−43.4%
Durkin Bryan T
Director
$19.64M (19)
−$19.64M
43,652
0.012%
$12.23M
−6.9%
Holzrichter Julie
Sr MD Chief Operating Officer
$13.06M (19)
−$13.06M
40,437
0.011%
$11.33M
+17.5%
Cutinho Sunil
Chief Information Officer
$12.25M (16)
−$12.25M
25,037
0.007%
$7.01M
+8.0%
Sammann Derek
Sr MD Gl Hd Commodities Mkts
$11.50M (15)
−$11.50M
39,835
0.011%
$11.16M
+1.0%
Piell Hilda Harris
Sr MD & Chief HR Officer
$11.38M (25)
−$11.38M
27,702
0.008%
$7.76M
−4.9%
Pietrowicz John W.
Sr MD Chief Financial Officer
$11.24M (18)
−$11.24M
55,238
0.015%
$15.47M
−7.2%
Kometer Kevin
Sr MD Chief Information Office
$11.22M (12) scheduled
−$11.22M
63,207
0.018%
$17.70M
+35.6%
SHEPARD WILLIAM R
Director
$10.84M (41)
+$10.84M
264,063
0.073%
$73.97M
+37.0%
Winkler Julie
Sr MD Chief Commercial Officer
$10.58M (19)
−$10.58M
31,561
0.009%
$8.84M
+101.7%
Tully Sean
Sr MD Global Hd Rates & OTC
$8.82M (11)
−$8.82M
22,087
0.006%
$6.19M
−16.3%
CRONIN KATHLEEN M
Sr MD Gen Counsel & Corp Secr
$8.55M (11) scheduled
−$8.55M
41,466
0.011%
$11.62M
+52.0%
Carey Charles P
Director
$6.86M (13)
−$6.86M
8,140
0.002%
$2.28M
−74.7%
SIEGEL HOWARD J
Director
$5.29M (8)
−$5.29M
70,731
0.020%
$19.81M
−13.7%
GEPSMAN MARTIN J
Director
$4.51M (27)
−$4.51M
25,644
0.007%
$7.18M
−40.1%
Vroman Ken
Chief Transformation Officer
$3.80M (5)
−$3.80M
20,232
0.006%
$5.67M
+116.0%
Bernacchi Jeffrey M.
Director
$3.51M (5)
−$3.51M
42,004
0.012%
$11.77M
−31.0%
TAYLOR KIMBERLY S
Former Sr MD&Pres.Clr&PostTrad
$3.04M (6) scheduled
−$3.04M
112,465
0.031%
$31.50M
+4.3%
Suskind Dennis
Director
$2.34M (12)
−$2.34M
3,344
<0.001%
$936.69K
−66.9%
Tobin Jack J
MD Chief Accounting Officer
$2.29M (6) scheduled
−$2.29M
25,762
0.007%
$7.22M
+93.9%
Cook Elizabeth A
Director
$1.89M (12)
−$1.89M
57,173
0.016%
$16.01M
−2.9%
Marcus Jonathan L
Sr MD General Counsel
$1.41M (4) scheduled
−$1.41M
7,192
0.002%
$2.01M
MELAMED LEO
Director
$1.14M (1)
−$1.14M
10,537
0.003%
$2.95M
−38.1%
GERDES LARRY G
Director
$1.06M (3)
−$1.06M
36,651
0.010%
$10.27M
+17.1%
Bitsberger Timothy S.
Director
$944.01K (10)
−$944.01K
11,766
0.003%
$3.30M
+19.8%
GLICKMAN DANIEL R
Director
$930.98K (7)
−$930.98K
14,756
0.004%
$4.13M
+6.6%
McCourt Timothy Francis
Sr MD Global Head Equity & FX
$860.58K (8)
−$860.58K
13,366
0.004%
$3.74M
+487.3%
Sprague Suzanne
COO & Global Head of Clearing
$627.96K (2)
−$627.96K
15,548
0.004%
$4.36M
+543.0%
SAVAGE TERRY L
Director
$526.62K (1)
−$526.62K
18,189
0.005%
$5.09M
+21.1%
Pankau Ronald A.
Director
$434.85K (10)
−$434.85K
3,906
0.001%
$1.09M
−14.8%
Lucas Deborah J
Director
$385.43K (1)
−$385.43K
4,533
0.001%
$1.27M
Lockett Phyllis M
Director
$294.55K (1)
−$294.55K
4,285
0.001%
$1.20M
Tierney Robert J JR
Director
$264.83K (1)
+$264.83K
14,345
0.004%
$4.02M
+91.3%
Ford Harold Eugene Jr.
Director
$263.53K (1)
−$263.53K
2,158
<0.001%
$604.48K
Fitzpatrick Lynne
President and CFO
$163.61K (1)
−$163.61K
26,661
0.007%
$7.47M
+231.6%
Kaye Daniel G
Director
$141.21K (1)
−$141.21K
4,845
0.001%
$1.36M
Spencer Michael A
Director
3,020,690
0.837%
$846.13M
SANDNER JOHN F
Director
149,218
0.041%
$41.80M
+0.5%
Hobert William W
Director
127,686
0.035%
$35.77M
+8.5%
WESCOTT DAVID J
Director
75,859
0.021%
$21.25M
+3.5%
Hertshten Gedon
Director
35,687
0.010%
$10.00M
+10.7%
Mulchrone Patrick J
Director
29,130
0.008%
$8.16M
+19.4%
POLLOCK ALEX J
Director
19,849
0.006%
$5.56M
+20.9%
Dennis Michael G.
Global Head of Fixed Income
10,723
0.003%
$3.00M
+19,689%
Dutra Ana
Director
7,176
0.002%
$2.01M
+235.5%
Maloney Patrick W
Director
4,743
0.001%
$1.33M
+118,475%
Seifu Rahael
Director
4,739
0.001%
$1.33M
CHOOKASZIAN DENNIS
Director
4,106
0.001%
$1.15M
Marchese John Clifford
Sr MD, General Counsel
3,598
<0.001%
$1.01M
+17.8%
Benesh Kathryn
Director
2,752
<0.001%
$770.85K
+17,156%
HARRIS YRA G
Director
1,885
<0.001%
$528.01K
+70.7%
Insider
Date
Role
Action
Shares
Price
Amount
Marcus Jonathan L
17 Mar 2026
Sr MD General Counsel
Sold on a plan
3,291
$333.37
$1.10M
Marcus Jonathan L
18 Sep 2025
Sr MD General Counsel
Sold on a plan
392
$262.00
$102.70K
Marcus Jonathan L
16 Sep 2025
Sr MD General Counsel
Sold on a plan
376
$258.96
$97.37K
Marcus Jonathan L
20 May 2025
Sr MD General Counsel
Sold on a plan
390
$277.50
$108.23K
Showing 250 of 380 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 808
Amendments (4/A) skipped 31
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 73
Sales at will 253
Transactions with no price 0
Shares from compensation/vesting 5,830,778
Sales filed before the plan box existed 174
History held since 1 Sep 2016